|
| Michael J Ackerman | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendix 1 for detailed information. Section numbers pertain to those in the full-text guideline. +ACC/AHA Representative. ++HRS Representative. SSACC/AHA Task Force on Performance Measures Liaison/HFSA Representative. ||ACC/AHA Task Force on Clinical Practice Guidelines Liaison. |
| David J Callans | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendix 1 for detailed information. Section numbers pertain to those in the full-text guideline. +ACC/AHA Representative. ++HRS Representative. SSACC/AHA Task Force on Performance Measures Liaison/HFSA Representative. ||ACC/AHA Task Force on Clinical Practice Guidelines Liaison. |
| Barbara J Deal | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendix 1 for detailed information. Section numbers pertain to those in the full-text guideline. +ACC/AHA Representative. ++HRS Representative. SSACC/AHA Task Force on Performance Measures Liaison/HFSA Representative. ||ACC/AHA Task Force on Clinical Practice Guidelines Liaison. |
| Gregg C Fonarow | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendix 1 for detailed information. Section numbers pertain to those in the full-text guideline. +ACC/AHA Representative. ++HRS Representative. SSACC/AHA Task Force on Performance Measures Liaison/HFSA Representative. ||ACC/AHA Task Force on Clinical Practice Guidelines Liaison. |
| Gregg C Fonarow | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendix 1 for detailed information. Section numbers pertain to those in the full-text guideline. +ACC/AHA Representative. ++HRS Representative. SSACC/AHA Task Force on Performance Measures Liaison/HFSA Representative. ||ACC/AHA Task Force on Clinical Practice Guidelines Liaison. |
| Mark A Hlatky | Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply see Appendix 1 for detailed information. Section numbers pertain to those in the full-text guideline. +ACC/AHA Representative. ++HRS Representative. SSACC/AHA Task Force on Performance Measures Liaison/HFSA Representative. ||ACC/AHA Task Force on Clinical Practice Guidelines Liaison. |